Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population

被引:42
|
作者
Vepsalainen, Saila
Parkinson, Michele
Helisalmi, Seppo
Mannermaa, Arto
Soininen, Hilkka
Tanzi, Rudolph E.
Bertram, Lars
Hiltunen, Mikko
机构
[1] Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
[3] Univ Kuopio, Clin Res Ctr Mediteknia, Brain Res Unit, FIN-70211 Kuopio, Finland
[4] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA
[5] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland
关键词
D O I
10.1136/jmg.2006.048470
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The gene for insulin-degrading enzyme (IDE), which is located at chromosome 10q24, has been previously proposed as a candidate gene for late-onset Alzheimer's disease (AD) based on its ability to degrade amyloid beta-protein. Genotyping of single nucleotide polymorphisms (SNPs) in the IDE gene in Finnish patients with AD and controls revealed SNPs rs4646953 and rs4646955 to be associated with AD, conferring an approximately two-fold increased risk. Single locus findings were corroborated by the results obtained from haplotype analyses. This suggests that genetic alterations in or near the IDE gene may increase the risk for developing AD.
引用
收藏
页码:606 / 608
页数:3
相关论文
共 50 条
  • [1] Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease
    Steven D. Edland
    [J]. Journal of Molecular Neuroscience, 2004, 23 : 213 - 217
  • [2] Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease
    Kurochkin, Igor V.
    Guarnera, Enrico
    Berezovsky, Igor N.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2018, 39 (01) : 49 - 58
  • [3] Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease
    Edland, SD
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (03) : 213 - 217
  • [4] Association study between insulin-degrading enzyme gene polymorphisms and Alzheimer's disease in Japanese population
    Sakai, A
    Ujike, H
    Nakatab, K
    Ishihara, T
    Terada, S
    Kuroda, S
    Imamura, T
    Yamamoto, M
    Fujisawa, Y
    Takehisa, Y
    Kanzaki, A
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S341 - S341
  • [5] Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
    Pivovarova, Olga
    Hoehn, Annika
    Grune, Tilman
    Pfeiffer, Andreas F. H.
    Rudovich, Natalia
    [J]. ANNALS OF MEDICINE, 2016, 48 (08) : 614 - 624
  • [6] Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-analysis
    Zhang, Huifeng
    Liu, Dan
    Huang, Huanhuan
    Zhao, Yujia
    Zhou, Hui
    [J]. CURRENT ALZHEIMER RESEARCH, 2018, 15 (07) : 610 - 617
  • [7] Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes
    Tian, Yue
    Jing, Guangchan
    Zhang, Mengren
    [J]. AGEING RESEARCH REVIEWS, 2023, 90
  • [8] Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease:: review and hypothesis
    Qiu, WQ
    Folstein, MF
    [J]. NEUROBIOLOGY OF AGING, 2006, 27 (02) : 190 - 198
  • [9] Insulin-degrading enzyme and Alzheimer's disease: A genetic association study in the Han Chinese
    Bian, L
    Yang, JD
    Guo, TW
    Sun, Y
    Duan, SW
    Chen, WY
    Pan, YX
    Feng, GY
    He, L
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 61 - 61
  • [10] Insulin-degrading enzyme in the Alzheimer's disease brain:: prominent localization in neurons and senile plaques
    Bernstein, HG
    Ansorge, S
    Riederer, P
    Reiser, M
    Frölich, L
    Bogerts, B
    [J]. NEUROSCIENCE LETTERS, 1999, 263 (2-3) : 161 - 164